Skip to main content
. 2016 Jul 15;6:29791. doi: 10.1038/srep29791

Table 2. Clinical features and outcomes of CD and UC patients with and without toxingenic C. difficile infection.

Factors CD P UC P
Positive N = 49 Negative N = 338 OR (95%CI) Positive N = 50 Negative N = 209 OR (95%CI)
Length of stay[Median (range),days] 33(3–330) 17(1–268) 1.02 (1.01–1.03) <0.001 21(3–118) 11(1–79) 1.03(1.02–1.05) <0.001
Hospitalization frequency[Median (range)] 7 (1–20) 3 (1–21) 1.28 (1.18–1.39) <0.001 3 (1–12) 1 (1–16) 1.27(1.13–1.42) <0.001
Bowel surgery [N (%)] 19(38.8) 84(24.9) 1.92 (1.03–3.58) 0.042 6(12.0) 6(2.9) 4.61(1.42–14.98) 0.011
Stool consistency [N (%)]
 Formed 22(44.9) 197(58.3)   10(20.0) 31(14.8)  
 Loose, pasty or watery 40(81.6) 301(89.1)   16(32.0) 69(33.0)  
 Bloody mucopurulent 9(18.4) 37(10.9) 0.148 34(68.0) 140(67.0) 0.451
Active stage [N (%)] 36(73.5) 183(54.1) 2.35 (1.20–4.58) 0.013 45(90.0) 189(90.4) 0.926
Severity [N (%)]
 Mild 18(36.7) 172(50.9) 1.0 (refrence)   23(44.9) 97(46.4)  
 Moderate 21(42.9) 123(36.4) 1.63 (0.83–3.19)   16(32.7) 74(35.4)  
 Severe 10(20.4) 43(12.7) 2.22 (0.96–5.16) 0.046 11(22.4) 38(18.2) 0.632